Back
Akoya Biosciences Vs. DocuSign Industry Stock Comparison
Sell
25
AKYA
Akoya Biosciences
Last Price:
$2.40
Seasonality Move:
-6.47%
Buy
79
DOCU
DocuSign
Last Price:
$95.04
Seasonality Move:
0.36%
Sell
25
Akoya Biosciences (AKYA)
is a Sell
Is Akoya Biosciences a Buy, Sell or Hold?
-
The current Akoya Biosciences [AKYA] share price is $2.41. The Score for AKYA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
AKYA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKYA Stock Price Chart
What is Akoya Biosciences's stock price today?
-
The Akoya Biosciences share price today is $2.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKYA is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 49.17 | Sell |
Chaikin Money Flow: | 57713 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.13 - 2.43) | Buy |
Bollinger Bands (100): | (2.24 - 2.96) | Sell |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.3 | Buy |
Relative Strength Index (14 RSI): | 58.86 | Buy |
Chaikin Money Flow: | -901725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.39 - 97.61) | Buy |
Bollinger Bands (100): | (55.72 - 84.04) | Buy |
AKYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.44 | Sell |
20-day SMA: | 2.32 | Buy |
50-day SMA: | 2.62 | Sell |
200-day SMA: | 2.91 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.41 | Buy |
50-day EMA: | 2.51 | Sell |
200-day EMA: | 3.1 | Sell |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.3 | Sell |
20-day SMA: | 91.52 | Buy |
50-day SMA: | 81.6 | Buy |
200-day SMA: | 63.13 | Buy |
8-day EMA: | 94.8 | Buy |
20-day EMA: | 91.58 | Buy |
50-day EMA: | 83.08 | Buy |
200-day EMA: | 66.81 | Buy |
Akoya Biosciences Earnings Growth & AKYA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.44 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.96 per share, and an increase next year of $0.66 per share.
Akoya Biosciences Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |